FDA Recalls Diabetes Drug Metformin For Cancer Concerns

The Federal Drug Administration is continuing its recall request for several companies that manufacture the extremely popular type II diabetes drug Metformin due to concerns that an ingredient is a known carcinogen.

I found this quite alarming as I am aware of several family members that are currently prescribed this medication.

The FDA indicated in a press release that "they are in contact with five firms to recommend they voluntarily recall their products. You can view the recall notices that are posted on the FDA’s website. There are additional manufacturers of the metformin ER formulation that supply a significant portion of the U.S. market, and their products are not being recalled. The FDA is continuing to work closely with manufacturers to ensure appropriate testing. Assessments are underway to determine whether metformin ER recalls will result in shortages and the agency will work closely with manufacturers to prevent or reduce any impact of shortages."

There is a distinction between the extended release product or "ER" and the non extended release version which at this time is not subject to any of these recalls. If you are currently prescribed Metformin you should contact your doctor or pharmacist to determine if the medication you are taking is the extended release version and is subject to these recalls can prescribe a replacement.

The FDA suggests "patients should continue taking metformin tablets even after recalls occur, until they consult with their health care professional. Patients with type 2 diabetes could face dangerous health risks if they stop taking their prescribed metformin. The FDA recommends that health care professionals continue to prescribe metformin when clinically appropriate; FDA testing has not shown NDMA in immediate release (IR) metformin products (the most commonly prescribed type of metformin).

CLICK HERE to view the complete press release by the FDA.